医学
普瑞巴林
安慰剂
临床试验
临床终点
随机对照试验
不利影响
神经病理性疼痛
阶段(地层学)
麻醉
内科学
生物
病理
古生物学
替代医学
作者
Xiaohui Guo,Tingting Zhang,Yang Yu,Wei‐Fang Zeng,Qingyuan Hu,Jianhua Ma,Yukun Li,Hongmei Li,Yawei Zhang,Jie Liu,Fang Bian,Wei Zhang,Fang Zhang,Shuguang Pang,Ya Li,Xiaohong Wu,Xulei Tang,Keqin Zhang,Tianrong Pan,Honglin Hu
出处
期刊:JAMA network open
[American Medical Association]
日期:2024-08-19
卷期号:7 (8): e2425614-e2425614
被引量:5
标识
DOI:10.1001/jamanetworkopen.2024.25614
摘要
Many patients with diabetic peripheral neuropathic pain (DPNP) experience inadequate relief, despite best available medical treatments. There are no approved and effective therapies for patients with DPNP in China.
科研通智能强力驱动
Strongly Powered by AbleSci AI